The effect on Endothelial progenitor cells (EPCs) by statin loading in all comers” with an Acute Coronary Syndrome (ACS). - Effect on EPCs by statin loading in 'all comers' with ACS

niversity Hospitals of North Midlands NHS Trust0 个研究点目标入组 40 人开始时间: 2016年12月8日最近更新: 2016年12月12日

适应症

试验速览

暂无简介。

•Patient-participants will be eligible for the study if they are;
•1.1.Admitted with an acute coronary syndrome
•2.Are statin naïve or receiving a statin other than atorvastatin, or atorvastatin at a dose less than 80mg daily.
•3.Able to give informed consent
•4.Have undergone coronary angiography / plasty
•5.Able to attend follow up visits
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 30
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 10

•Patient-participants will be excluded if
•1.Atorvastatin is contraindicated (e.g. allergic to excipient)
•2.Women of child bearing potential unless they are using a recognised effective form of contraception or are not sexually active, and have no intention of becoming sexually active during the course of the trial.
•3.Women who are breastfeeding

发起方

niversity Hospitals of North Midlands NHS Trust